Drew McCartney has joined BelHealth Investment Partners’ operating committee. Recently, McCartney served as the Executive-In-Residence at DW Healthcare Partners. Port Washington, N.Y.-based BelHealth is a PE firm focused on the small-cap healthcare industry.
New York – August 16, 2011–BelHealth Investment Partners L.P. (“BelHealth”) today announced that Drew McCartney has joined BelHealth’s operating committee.
Mr. McCartney has served in a variety of executive roles, including as CEO, for companies in the medical devices, services and informatics industry. Mr. McCartney started his career with American Hospital Supply and was VP of Global Marketing with Baxter Biotech. Mr. McCartney developed and executed the global strategic marketing direction for Baxter’s $250 million blood systems unit, through which the company achieved significant sales growth, new product introductions and licensing relationships with partners worldwide.
More recently, Mr. McCartney served as the Executive-In-Residence at DW Healthcare Partners, a healthcare focused private equity fund. Prior to that, Drew was CEO of First Circle Medical and raised substantial capital from a combination of Boston Scientific Corporation, Tyco International and private equity and established commercial operations in Europe and China. Mr. McCartney also led a private equity-backed catheter stabilization company through a critical restructuring while developing and commercializing a number of technologies overseas and domestically.
Previously, Mr. McCartney was with the Battelle Memorial Institute and led their expansion into new healthcare markets in drug delivery and clinical informatics. Mr. McCartney holds a bachelor’s degree in Government from the University of Virginia.
The members of BelHealth’s Operating Committee are accomplished executives with significant experience in managing and growing healthcare companies. The Operating Committee will provide the Fund’s portfolio companies with disciplined leadership and strategic planning to realize maximum growth potential. Dennis Drislane, Chairman of BelHealth’s Operating Committee said “Drew is a seasoned executive and brings three decades of entrepreneurial and private equity experience to our team. His experience and understanding of the broad spectrum of the healthcare industry will be a real asset to our operating team in continuing to enhance value at BelHealth’s portfolio companies.”
Bert Brodsky, Managing Partner of BelHealth, added, “I am excited to have Drew as a key member of the BelHealth team and believe BelHealth and its portfolio will benefit greatly from his expertise and leadership. I look forward to a successful partnership.”
Drew McCartney said “I am thrilled to become an integral part of BelHealth’s team. I was fortunate to learn the private equity (PE) business from an exceptional team at DW Healthcare Partners. The opportunity to assume a broader role and have an immediate impact at an aggressive healthcare PE fund is a challenge I welcome. Upon meeting BelHealth’s managing partners, I was enthused to learn our operating philosophy is uniformly aligned while the track record of the founders, as both operators and investors, is exemplary. I intend to deliver significant value to their portfolio companies.“
About BelHealth Investment Partners
BelHealth Investment Partners L.P. (“BelHealth”) is a private equity buyout fund focused exclusively on the small-cap healthcare industry. BelHealth acquires majority positions in healthcare companies that the BelHealth Team believes are undervalued or undermanaged and would benefit from the vast entrepreneurial and operating experience that BelHealth can deliver. Applying an active, hands-on approach to governance, BelHealth utilizes its experience to drive revenue and profit growth and achieve superior returns for its investors. For more information about BelHealth, please go to its website: www.BelHealth.com.